JCI - Citations to Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members

Citations to this article

Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members

Jennifer M. MacArthur, … , Joseph L. Witztum, Jeffrey D. Esko

Jennifer M. MacArthur, … , Joseph L. Witztum, Jeffrey D. Esko

Published January 2, 2007
Citation Information: J Clin Invest. 2007;117(1):153-164. https://doi.org/10.1172/JCI29154.

View: Text | PDF

Research Article

Total citations by year

Year:	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	Total
Citations:	3	4	5	5	4	2	5	4	7	5	5	9	6	8	9	5	11	8	1	106

Citation information

Citations to this article (106)

Title and authors	Publication	Year
Lipidome disruption in Alzheimer’s disease brain: detection, pathological mechanisms, and therapeutic implications He S, Xu Z, Han X	Molecular Neurodegeneration	2025
Heparan sulfate chains in hepatocellular carcinoma Guyot E	Gastroenterology Report	2025
Glycosaminoglycan-driven lipoprotein uptake protects tumours from ferroptosis. Calhoon D, Sang L, Ji F, Bezwada D, Hsu SC, Cai F, Kim N, Basu A, Wu R, Pimentel A, Brooks B, La K, Paulina Serrano A, Cassidy DL, Cai L, Toffessi-Tcheuyap V, Moussa ME, Uritboonthai W, Hoang LT, Kolli M, Jackson B, Margulis V, Siuzdak G, Brugarolas J, Corbin I, Pratt DA, Weiss RJ, DeBerardinis RJ, Birsoy K, Garcia-Bermudez J	Nature	2025
Protective Effects of High-Density Lipoprotein on Cancer Risk: Focus on Multiple Myeloma Allegra A, Murdaca G, Mirabile G, Gangemi S	Biomedicines	2024
Glycosaminoglycan-mediated lipoprotein uptake protects cancer cells from ferroptosis Calhoon D, Sang L, Bezwada D, Kim N, Basu A, Hsu SC, Pimentel A, Brooks B, La K, Serrano AP, Cassidy DL, Cai L, Toffessi-Tcheuyap V, Margulis V, Cai F, Brugarolas J, Weiss RJ, DeBerardinis RJ, Birsoy K, Garcia-Bermudez J		2024
Time restricted feeding reduces atherosclerosis in LDLR KO mice but not in ApoE knockout mice Chaix A, Lin T, Ramms B, Cutler RG, Le T, Lopez C, Miu P, Pinto AF, Saghatelian A, Playford MP, Mehta NN, Mattson MP, Gordts P, Witztum JL, Panda S	Arteriosclerosis, thrombosis, and vascular biology	2024
A Tale of Two Receptors Strickland DK, Cooper JM	Arteriosclerosis, thrombosis, and vascular biology	2024
Regulation of autophagy, lipid metabolism, and neurodegenerative pathology by heparan sulfate proteoglycans Schultheis N, Becker R, Berhanu G, Kapral A, Roseman M, Shah S, Connell A, Selleck S	Frontiers in Genetics	2023
Protective Effects of Lactobacillus gasseri against High-Cholesterol Diet-Induced Fatty Liver and Regulation of Host Gene Expression Profiles He T, Lykov N, Luo X, Wang H, Du Z, Chen Z, Chen S, Zhu L, Zhao Y, Tzeng C	International journal of molecular sciences	2023
Pentosan Polysulfate Affords Pleotropic Protection to Multiple Cells and Tissues Smith MM, Melrose J	Pharmaceuticals	2023
Glycocalyx engineering with heparan sulfate mimetics attenuates Wnt activity during adipogenesis to promote glucose uptake and metabolism Trieger GW, Pessentheiner AR, Purcell SC, Green CR, DeForest N, Willert K, Majithia AR, Metallo CM, Godula K, Gordts PL	The Journal of biological chemistry	2023
Apolipoprotein C3: form begets function Bornfeldt KE	Journal of lipid research	2023
Interventional Hepatic ApoC-III Knockdown Improves Atherosclerotic Plaque Stability and Remodeling upon Triglyceride Lowering Bastian Ramms, Sohan Patel, Xiaoli Sun, Ariane R Pessentheiner, G. Ducasa, Adam E Mullick, Richard G. Lee, Rosanne Crooke, Sotirios Tsimikas, Joseph Witztum, Philip Gordts	JCI Insight	2022
Physiology and Pathophysiology of Heparan Sulfate in Animal Models: Its Biosynthesis and Degradation R Mashima, T Okuyama, M Ohira	International journal of molecular sciences	2022
Heparanase Inhibition Prevents Liver Steatosis in E₀ Mice. Kinaneh S, Hijaze W, Mansour-Wattad L, Hammoud R, Zaidani H, Kabala A, Hamoud S	Journal of Clinical Medicine	2022
Diet-induced prediabetes: Effects on the activity of the renin-angiotensin-aldosterone system in selected organs. Mkhize BC, Mosili P, Ngubane PS, Sibiya NH, Khathi A	Journal of Diabetes Investigation	2022
N-Acetylcysteine and Other Sulfur-Donors as a Preventative and Adjunct Therapy for COVID-19. du Preez HN, Aldous C, Kruger HG, Johnson L		2022
Heparan Sulfate Glycosaminoglycans: (Un)Expected Allies in Cancer Clinical Management I Faria-Ramos, J Poças, C Marques, J Santos-Antunes, G Macedo, CA Reis, A Magalhães	Biomolecules	2021
Hypercholesterolemia in Progressive Renal Failure Is Associated with Changes in Hepatic Heparan Sulfate - PCSK9 Interaction P Shrestha, S Adepu, RR Vivès, RE Masri, A Klooster, F Kaptein, W Dam, SJ Bakker, H van Goor, B van de Sluis, J van den Born	Journal of the American Society of Nephrology : JASN	2021
The Lipoprotein Transport System in the Pathogenesis of Multiple Myeloma: Advances and Challenges V Lazaris, A Hatziri, A Symeonidis, KE Kypreos	Frontiers in Oncology	2021
A Systems View of the Heparan Sulfate Interactome AG Toledo, JT Sorrentino, DR Sandoval, J Malmström, NE Lewis, JD Esko	Journal of Histochemistry & Cytochemistry	2021
Potential Use of Anti-Inflammatory Synthetic Heparan Sulfate to Attenuate Liver Damage K Arnold, YE Liao, J Liu	Biomedicines	2020
ADAMTS-5: A difficult teenager turning 20 S Santamaria	International Journal of Experimental Pathology	2020
Triglyceride-rich lipoprotein binding and uptake by heparan sulfate proteoglycan receptors in a CRISPR/Cas9 library of Hep3B mutants F Anower-E-Khuda, G Singh, Y Deng, PL Gordts, JD Esko	Glycobiology	2019
ApoC-III ASO promotes tissue LPL activity in the absence of apoE-mediated TRL clearance B Ramms, S Patel, C Nora, AR Pessentheiner, MW Chang, CR Green, GJ Golden, P Secrest, RM Krauss, CM Metallo, C Benner, VJ Alexander, JL Witztum, S Tsimikas, JD Esko, PL Gordts	Journal of lipid research	2019
Hepatic heparan sulfate is a master regulator of hepcidin expression and iron homeostasis in human hepatocytes and mice M Poli, F Anower-E-Khuda, M Asperti, P Ruzzenenti, M Gryzik, A Denardo, PL Gordts, P Arosio, JD Esko	The Journal of biological chemistry	2019
ApoC-III Glycoforms Are Differentially Cleared by Hepatic TRL (Triglyceride-Rich Lipoprotein) Receptors NC Kegulian, B Ramms, S Horton, O Trenchevska, D Nedelkov, MJ Graham, RG Lee, JD Esko, HN Yassine, PL Gordts	Arteriosclerosis, thrombosis, and vascular biology	2019
ApoF knockdown increases cholesteryl ester transfer to LDL and impairs cholesterol clearance in fat-fed hamsters RE Morton, Y Liu, L Izem	Journal of lipid research	2019
The heparan sulfate proteoglycan grip on hyperlipidemia and atherosclerosis PL Gordts, JD Esko	Matrix biology : journal of the International Society for Matrix Biology	2018
Heparan sulfate S-domains and extracellular sulfatases (Sulfs): their possible roles in protein aggregation diseases K Nishitsuji	Glycoconjugate Journal	2018
SGLT2 inhibition reduces atherosclerosis by enhancing lipoprotein clearance in Ldlr −/− type 1 diabetic mice A Al-Sharea, AJ Murphy, LA Huggins, Y Hu, IJ Goldberg, PR Nagareddy	Atherosclerosis	2018
γ-Secretase Inhibition Lowers Plasma Triglyceride-Rich Lipoproteins by Stabilizing the LDL Receptor KJ Kim, IJ Goldberg, MJ Graham, M Sundaram, E Bertaggia, SX Lee, L Qiang, RA Haeusler, D Metzger, P Chambon, Z Yao, HN Ginsberg, UB Pajvani	Cell Metabolism	2018
Sustained Placental Growth Factor-2 Treatment Does Not Aggravate Advanced Atherosclerosis in Ischemic Cardiomyopathy M Wu, P Pokreisz, M Swinnen, E Caluwe, H Gillijns, NV Driessche, A Casazza, E Verbeken, D Collen, S Janssens	Journal of Cardiovascular Translational Research	2017
Hepatic Tm6sf2 overexpression affects cellular ApoB-trafficking, plasma lipid levels, hepatic steatosis and atherosclerosis N Ehrhardt, ME Doche, S Chen, HZ Mao, MT Walsh, C Bedoya, M Guindi, W Xiong, JI Irudayam, J Iqbal, S Fuchs, SW French, MM Hussain, M Arditi, V Arumugaswami, M Péterfy	Human Molecular Genetics	2017
Targeting heparin and heparan sulfate protein interactions RJ Weiss, JD Esko, Y Tor	Organic & Biomolecular Chemistry	2017
SMAD About Hepatitis C Virus Cell Entry and Liver Disease CC Colpitts, TF Baumert	Gastroenterology	2017
Diet-induced hypercholesterolemia alters liver glycosaminoglycans and associated-lipoprotein receptors in rats G Kiran, UJ Rao, PV Salimath, ND Chilkunda	Journal of Physiology and Biochemistry	2017
Advances in the pathogenesis and possible treatments for multiple hereditary exostoses from the 2016 international MHE conference AQ Phan, M Pacifici, JD Esko	Connective Tissue Research	2017
Hepatic and Aortic Arch Expression and Serum Levels of Syndecan-1 in ApoE Mice EI Leonova, ES Sadovnikova, ER Shaykhutdinova, OV Galzitskaya, AN Murashev, AS Solonin	The open biochemistry journal	2017
ApoC-III Modulates Clearance of Triglyceride-Rich Lipoproteins Through LDL Family Receptors Philip L.S.M. Gordts, Ryan Nock, Ni-Huiping Son, Bastian Ramms, Irene Lew, Jon Gonzales, Bryan Thacker, Debapriya Basu, Richard Lee, Adam Mullick, Mark Graham, Ira J. Goldberg, rosanne Crooke, Joseph Witztum, Jeffrey D. Esko	Journal of Clinical Investigation	2016
Biological roles of glycans A Varki	Glycobiology	2016
Glycosaminoglycan remodeling during diabetes and the role of dietary factors in their modulation V Gowd	World journal of diabetes	2016
Disialylated apolipoprotein C-III proteoform is associated with improved lipids in prediabetes and type 2 diabetes J Koska, H Yassine, O Trenchevska, S Sinari, DC Schwenke, FT Yen, D Billheimer, RW Nelson, D Nedelkov, PD Reaven	Journal of lipid research	2016
Effect of alirocumab on specific lipoprotein non-high-density lipoprotein cholesterol and subfractions as measured by the vertical auto profile method: analysis of 3 randomized trials versus placebo PP Toth, SC Hamon, SR Jones, SS Martin, PH Joshi, KR Kulkarni, P Banerjee, C Hanotin, EM Roth, JM McKenney	Lipids in Health and Disease	2016
Ext1 heterozygosity causes a modest effect on postprandial lipid clearance in humans HL Mooij, SJ Moens, PL Gordts, KI Stanford, EM Foley, MA van Boogert, JJ Witjes, HC Hassing, MW Tanck, MA van de Sande, JH Levels, JJ Kastelein, ES Stroes, GM Dallinga-Thie, JD Esko, M Nieuwdorp	Journal of lipid research	2015
Novel method for reducing plasma cholesterol: a ligand replacement therapy GM Anantharamaiah, D Goldberg	Clinical Lipidology	2015
Role of Deacetylase Activity of N -Deacetylase/ N -Sulfotransferase 1 in Forming N -Sulfated Domain in Heparan Sulfate W Dou, Y Xu, V Pagadala, LC Pedersen, J Liu	The Journal of biological chemistry	2015
Serglycin protects against high fat diet-induced increase in serum LDL in mice AJ Meen, CA Drevon, G Pejler, TG Jenssen, OK Olstad, M Åbrink, SO Kolset	Glycoconjugate Journal	2015
Kinetic Studies to Elucidate Impaired Metabolism of Triglyceride-rich Lipoproteins in Humans M Adiels, A Mardinoglu, MR Taskinen, J Borén	Frontiers in physiology	2015
microRNA-379 couples glucocorticoid hormones to dysfunctional lipid homeostasis RM de Guia, AJ Rose, A Sommerfeld, O Seibert, D Strzoda, A Zota, Y Feuchter, A Krones-Herzig, T Sijmonsma, M Kirilov, C Sticht, N Gretz, G Dallinga-Thie, S Diederichs, N Kloting, M Bluher, MB Diaz, S Herzig	The EMBO Journal	2014
Syndecan-1 is required to maintain intradermal fat and prevent cold stress I Kasza, Y Suh, D Wollny, RJ Clark, A Roopra, RJ Colman, OA MacDougald, TA Shedd, DW Nelson, MI Yen, CL Yen, CM Alexander	PLoS genetics	2014
Human Genetic Disorders and Knockout Mice Deficient in Glycosaminoglycan S Mizumoto, S Yamada, K Sugahara	BioMed Research International	2014
Reducing Macrophage Proteoglycan Sulfation Increases Atherosclerosis and Obesity through Enhanced Type I Interferon Signaling PL Gordts, EM Foley, R Lawrence, R Sinha, C Lameda-Diaz, L Deng, R Nock, CK Glass, A Erbilgin, AJ Lusis, JL Witztum, JD Esko	Cell Metabolism	2014
Syndecan 4 Is Involved in Mediating HCV Entry through Interaction with Lipoviral Particle-Associated Apolipoprotein E M Lefèvre, DJ Felmlee, M Parnot, TF Baumert, C Schuster	PloS one	2014
Equivalent binding of wild-type lipoprotein lipase (LPL) and S447X-LPL to GPIHBP1, the endothelial cell LPL transporter K Turlo, CS Leung, JJ Seo, CN Goulbourne, O Adeyo, P Gin, C Voss, A Bensadoun, LG Fong, SG Young, AP Beigneux	Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids	2014
SULF2 strongly prediposes to fasting and postprandial triglycerides in patients with obesity and type 2 diabetes mellitus: SULF2 and Triglycerides in Obesity HC Hassing, RP Surendran, B Derudas, A Verrijken, SM Francque, HL Mooij, SJ Moens, LM Hart, G Nijpels, JM Dekker, KJ Williams, ES Stroes, LF van Gaal, B Staels, M Nieuwdorp, GM Dallinga-Thie	Obesity	2014
Hyperlipoproteinemia Type 3: The Forgotten Phenotype PN Hopkins, EA Brinton, MN Nanjee	Current Atherosclerosis Reports	2014
Apolipoprotein E synthesized by adipocyte and apolipoprotein E carried on lipoproteins modulate adipocyte triglyceride content Y Li, L Liu	Lipids in Health and Disease	2014
Apolipoproteins E and AV Mediate Lipoprotein Clearance by Hepatic Proteoglycans Jon C. Gonzales, Philip L.S.M. Gordts, Erin M. Foley, Jeffrey D. Esko	Journal of Clinical Investigation	2013
The regulation of ApoB metabolism by insulin ME Haas, AD Attie, SB Biddinger	Trends in Endocrinology & Metabolism	2013
Complexity of microRNA function and the role of isomiRs in lipid homeostasis KC Vickers, P Sethupathy, J Baran-Gale, AT Remaley	Journal of lipid research	2013
Hepatitis C virus, cholesterol and lipoproteins--impact for the viral life cycle and pathogenesis of liver disease DJ Felmlee, ML Hafirassou, M Lefevre, TF Baumert, C Schuster	Viruses	2013
Genetic variation in SULF2 is associated with postprandial clearance of triglyceride-rich remnant particles and triglyceride levels in healthy subjects N Matikainen, MA Burza, S Romeo, A Hakkarainen, M Adiels, L Folkersen, P Eriksson, N Lundbom, E Ehrenborg, M Orho-Melander, MR Taskinen, J Borén	PloS one	2013
Hepatic Remnant Lipoprotein Clearance by Heparan Sulfate Proteoglycans and Low-Density Lipoprotein Receptors Depend on Dietary Conditions in Mice EM Foley, PL Gordts, KI Stanford, JC Gonzales, R Lawrence, N Stoddard, JD Esko	Arteriosclerosis, thrombosis, and vascular biology	2013
The Glomerular Basement Membrane as a Model System to Study the Bioactivity of Heparan Sulfate Glycosaminoglycans KJ McCarthy, DJ Wassenhove-McCarthy	Microscopy and Microanalysis	2012
Low Density Lipoprotein Receptor-Related Protein 1 Dependent Endosomal Trapping and Recycling of Apolipoprotein E A Laatsch, M Panteli, M Sornsakrin, B Hoffzimmer, T Grewal, J Heeren	PloS one	2012
Lipoproteins in Drosophila melanogaster—Assembly, Function, and Influence on Tissue Lipid Composition W Palm, JL Sampaio, M Brankatschk, M Carvalho, A Mahmoud, A Shevchenko, S Eaton, RP Kühnlein	PLoS genetics	2012
Lipids and HCV MF Bassendine, DA Sheridan, SH Bridge, DJ Felmlee, RD Neely	Seminars in Immunopathology	2012
A new, powerful player in lipoprotein metabolism: brown adipose tissue A Bartelt, M Merkel, J Heeren	Journal of Molecular Medicine	2012
Retinyl ester hydrolases and their roles in vitamin A homeostasis☆ R Schreiber, U Taschler, K Preiss-Landl, N Wongsiriroj, R Zimmermann, A Lass	Biochimica et Biophysica Acta	2012
Impaired LDL Receptor-Related Protein 1 Translocation Correlates with Improved Dyslipidemia and Atherosclerosis in apoE-Deficient Mice PL Gordts, A Bartelt, SK Nilsson, W Annaert, C Christoffersen, LB Nielsen, J Heeren, AJ Roebroek	PloS one	2012
Inhibition of hepatic sulfatase-2 In Vivo: A novel strategy to correct diabetic dyslipidemia HC Hassing, H Mooij, S Guo, BP Monia, K Chen, W Kulik, GM Dallinga-Thie, M Nieuwdorp, ES Stroes, KJ Williams	Hepatology	2012
Role of heparanase on hepatic uptake of intestinal derived lipoprotein and fatty streak formation in mice D Planer, S Metzger, E Zcharia, ID Wexler, I Vlodavsky, T Chajek-Shaul	PloS one	2011
Shedding of syndecan-1 from human hepatocytes alters VLDL clearance Y Deng, EM Foley, JC Gonzales, PL Gordts, Y Li, JD Esko	Hepatology	2011
Heparan sulfate proteoglycans S Sarrazin, WC Lamanna, JD Esko	Cold Spring Harbor perspectives in biology	2011
Changes in Expression of Proteoglycan Core Proteins and Heparan Sulfate Enzymes in the Developing and Adult Murine Aorta N Adhikari, M Carlson, B Lerman, JL Hall	Journal of Cardiovascular Translational Research	2011
The Dominating Role of N-Deacetylase/N-Sulfotransferase 1 in Forming Domain Structures in Heparan Sulfate* J Sheng, R Liu, Y Xu, J Liu	The Journal of biological chemistry	2011
Glucuronic Acid Epimerase is Associated with Plasma Triglyceride and High-Density Lipoprotein Cholesterol Levels in Turks U Hodoğlugil, DW Williamson, Y Yu, LA Farrer, RW Mahley	Annals of Human Genetics	2011
Postprandial triglyceride-rich lipoproteins induce hepatic insulin resistance in HepG2 cells independently of their receptor-mediated cellular uptake T Tatarczyk, C Ciardi, A Niederwanger, M Kranebitter, JR Patsch, MT Pedrini	Molecular and Cellular Endocrinology	2011
MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins KC Vickers, BT Palmisano, BM Shoucri, RD Shamburek, AT Remaley	Nature Cell Biology	2011
Lowered expression of heparan sulfate/heparin biosynthesis enzyme N-deacetylase/n-sulfotransferase 1 results in increased sulfation of mast cell heparin A Dagälv, K Holmborn, L Kjellén, M Abrink	The Journal of biological chemistry	2011
Deletion of the basement membrane heparan sulfate proteoglycan type XVIII collagen causes hypertriglyceridemia in mice and humans JR Bishop, MR Passos-Bueno, L Fong, KI Stanford, JC Gonzales, E Yeh, SG Young, A Bensadoun, JL Witztum, JD Esko, KS Moulton	PloS one	2010
Insulin-dependent diabetes mellitus in mice does not alter liver heparan sulfate JR Bishop, E Foley, R Lawrence, JD Esko	The Journal of biological chemistry	2010
Type 2 Diabetes in Mice Induces Hepatic Overexpression of Sulfatase 2, a Novel Factor That Suppresses Uptake of Remnant Lipoproteins K Chen, ML Liu, L Schaffer, M Li, G Boden, X Wu, KJ Williams	Hepatology	2010
Requirements for receptor engagement during infection by adenovirus complexed with blood coagulation factor X AC Bradshaw, AL Parker, MR Duffy, L Coughlan, N Rooijen, VM Kähäri, SA Nicklin, AH Baker	PLoS pathogens	2010
Tropism-Modification Strategies for Targeted Gene Delivery Using Adenoviral Vectors L Coughlan, R Alba, AL Parker, AC Bradshaw, IA McNeish, SA Nicklin, AH Baker	Viruses	2010
Syndecan-1, the Primary Heparan Sulfate Proteoglycan Mediating Hepatic Triglyceride-Rich Lipoprotein Clearance In Vivo Kristin I. Stanford, Joseph R. Bishop, Erin M. Foley, Jon C. Gonzalez, Ingrid R. Niesman, Joseph L. Witztum, Jeffrey D. Esko	Journal of Clinical Investigation	2009
Heparan sulfate proteoglycans are receptors for the cell-surface trafficking and biological activity of transglutaminase-2 A Scarpellini, R Germack, H Lortat-Jacob, T Muramatsu, E Billett, T Johnson, EA Verderio	The Journal of biological chemistry	2009
Heparan sulfate 2-O-sulfotransferase is required for triglyceride-rich lipoprotein clearance KI Stanford, L Wang, J Castagnola, D Song, JR Bishop, JR Brown, R Lawrence, X Bai, H Habuchi, M Tanaka, WV Cardoso, K Kimata, JD Esko	The Journal of biological chemistry	2009
Regulation of fatty acid uptake into tissues: lipoprotein lipase- and CD36-mediated pathways IJ Goldberg, RH Eckel, NA Abumrad	Journal of lipid research	2009
Improved cholesterol phenotype analysis by a model relating lipoprotein life cycle processes to particle size DB van Schalkwijk, AA de Graaf, B Ommen, K Bochove, PC Rensen, LM Havekes, NC van de Pas, HC Hoefsloot, J der Greef, AP Freidig	Journal of lipid research	2009
The effect of old age on apolipoprotein E and its receptors in rat liver T Sabaretnam, J O'Reilly, L Kritharides, DG le Couteur	Age (Dordrecht, Netherlands)	2009
Oxygen-mediated enhancement of primary hepatocyte metabolism, functional polarization, gene expression, and drug clearance S Kidambi, RS Yarmush, E Novik, P Chao, ML Yarmush, Y Nahmias	Proceedings of the National Academy of Sciences	2009
Differential expression of lumican and fatty acid binding protein-1: new insights into the histologic spectrum of nonalcoholic fatty liver disease M Charlton, K Viker, A Krishnan, S Sanderson, B Veldt, AJ Kaalsbeek, M Kendrick, G Thompson, F Que, J Swain, M Sarr	Hepatology	2009
The metabolism of triglyceride-rich lipoproteins revisited: new players, new insight GM Dallinga-Thie, R Franssen, HL Mooij, ME Visser, HC Hassing, F Peelman, JJ Kastelein, M Péterfy, M Nieuwdorp	Atherosclerosis	2009
Cell type-specific requirements for heparan sulfate biosynthesis at the Drosophila neuromuscular junction: effects on synapse function, membrane trafficking, and mitochondrial localization Y Ren, CA Kirkpatrick, JM Rawson, M Sun, SB Selleck	The Journal of neuroscience : the official journal of the Society for Neuroscience	2009
The Recovery Time Course of the Endothelial Cell Glycocalyx In Vivo and Its Implications In Vitro DR Potter, J Jiang, ER Damiano	Circulation research	2009
Molecular processes that handle – and mishandle – dietary lipids Kevin Jon Williams	Journal of Clinical Investigation	2008
Abnormal patterns of lipoprotein lipase release into the plasma in GPIHBP1-deficient mice MM Weinstein, L Yin, AP Beigneux, BS Davies, P Gin, K Estrada, K Melford, JR Bishop, JD Esko, GM Dallinga-Thie, LG Fong, A Bensadoun, SG Young	The Journal of biological chemistry	2008
Role of the N- and C-Terminal Domains in Binding of Apolipoprotein E Isoforms to Heparan Sulfate and Dermatan Sulfate: A Surface Plasmon Resonance Study Y Yamauchi, N Deguchi, C Takagi, M Tanaka, P Dhanasekaran, M Nakano, T Handa, MC Phillips, S Lund-Katz, H Saito	Biochemistry	2008
LDL receptor-related protein 1: unique tissue-specific functions revealed by selective gene knockout studies AP Lillis, LB van Duyn, JE Murphy-Ullrich, DK Strickland	Physiological reviews	2008
Tetrasulfated disaccharide unit in heparan sulfate: enzymatic formation and tissue distribution H Mochizuki, K Yoshida, Y Shibata, K Kimata	The Journal of biological chemistry	2008
Altered heparan sulfate structure in mice with deleted NDST3 gene function SR Pallerla, R Lawrence, L Lewejohann, Y Pan, T Fischer, U Schlomann, X Zhang, JD Esko, K Grobe	The Journal of biological chemistry	2008
Infection induces a positive acute phase apolipoprotein E response from a negative acute phase gene: role of hepatic LDL receptors L Li, PA Thompson, RL Kitchens	Journal of lipid research	2008
A role for a lithium-inhibited Golgi nucleotidase in skeletal development and sulfation JP Frederick, AT Tafari, SM Wu, LC Megosh, ST Chiou, RP Irving, JD York	Proceedings of the National Academy of Sciences	2008
Atherogenic remnant lipoproteins: trap, transfer, and internalization role for proteoglycans Robert W. Mahley, Yadong Huang	Journal of Clinical Investigation	2007

Advertisement